|
Low doses of MDS drug...
have potential for treating other cancers.
http://www.sciencedaily.com/releases...0323001414.htm
It's good to see a shift in thinking about how to utilize low doses versus the higher doses we see used for cancer. Maybe we are finally getting to point where collateral damage will be minimal making treatments more tolerable.
__________________
Marlene, wife to John DX w/SAA April 2002, Stable partial remission; Treated with High Dose Cytoxan, Johns Hopkins, June 2002. Final phlebotomy 11/2016. As of July 2021 HGB 12.0, WBC 4.70/ANC 3.85, Plts 110K.
|